Buprenorphine Hydrochloride Patent Expiration
Buprenorphine Hydrochloride is Used for managing severe, long-term pain when other treatments are insufficient, through transmucosal delivery of buprenorphine. It was first introduced by Indivior Inc
Buprenorphine Hydrochloride Patents
Given below is the list of patents protecting Buprenorphine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Belbuca | US9901539 | Transmucosal drug delivery devices for use in chronic pain relief | Dec 21, 2032 | Bdsi |
| Belbuca | US8147866 | Transmucosal delivery devices with enhanced uptake | Jul 23, 2027 | Bdsi |
| Belbuca | US9655843 | Transmucosal delivery devices with enhanced uptake | Jul 23, 2027 | Bdsi |
| Probuphine | US7736665 | Implantable polymeric device for sustained release of buprenorphine |
Apr 25, 2024
(Expired) | Reacx Pharms |
| Belbuca | US7579019 | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
Jan 22, 2020
(Expired) | Bdsi |
| Belbuca | US6159498 | Bioerodable film for delivery of pharmaceutical compounds of mucosal surfaces |
Oct 18, 2016
(Expired) | Bdsi |
Buprenorphine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List